{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T07:08:53Z","timestamp":1648624133969},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1477-7517-11-33","type":"journal-article","created":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T02:01:50Z","timestamp":1416621710000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional study"],"prefix":"10.1186","volume":"11","author":[{"given":"Elisabet","family":"Arribas-Ibar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"S\u00e1nchez-Niub\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Maj\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f2nia","family":"Domingo-Salvany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Brugal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,22]]},"reference":[{"key":"339_CR1","volume-title":"Annual Report 2009. The State of the Drug Problem in Europe","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2009","unstructured":"European Monitoring Centre for Drugs and Drug Addiction: Annual Report 2009. The State of the Drug Problem in Europe. 2009, Luxembourg: Publications Office of the European Union"},{"key":"339_CR2","volume-title":"Annual report 2012: The state of the drugs problem in Europe","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2012","unstructured":"European Monitoring Centre for Drugs and Drug Addiction: Annual report 2012: The state of the drugs problem in Europe. 2012, Luxembourg: Publications Office of the European Union"},{"key":"339_CR3","doi-asserted-by":"crossref","DOI":"10.18356\/94bbf1f4-en","volume-title":"World drug report 2012","author":"United Nations Office on Drugs and Crime","year":"2012","unstructured":"United Nations Office on Drugs and Crime: World drug report 2012. 2012, Vienna"},{"key":"339_CR4","doi-asserted-by":"crossref","DOI":"10.18356\/d30739c2-en","volume-title":"World drug report 2013","author":"United Nations Office on Drugs and Crime","year":"2013","unstructured":"United Nations Office on Drugs and Crime: World drug report 2013. 2013, Vienna"},{"key":"339_CR5","volume-title":"Insights","author":"J Strang","year":"2013","unstructured":"Strang J, Groshkova T, Metrebian N: Insights. 2013, Lisbon: New heroin assisted-treatment. Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond. European Monitoring Centre for Drugs and Drug Addiction"},{"key":"339_CR6","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","volume":"376","author":"DJ Nutt","year":"2010","unstructured":"Nutt DJ, King LA, Phillips LD: Drug harms in the UK: a multicriteria decision analysis. Lancet. 2010, 376: 1558-1565. 10.1016\/S0140-6736(10)61462-6.","journal-title":"Lancet"},{"key":"339_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jurban\/jtg022","volume":"80","author":"S Darke","year":"2003","unstructured":"Darke S, Hall W: Heroin overdose: research and evidence-based intervention. J Urban Health. 2003, 80: 189-200. 10.1093\/jurban\/jtg022.","journal-title":"J Urban Health"},{"key":"339_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","volume":"100","author":"MT Brugal","year":"2005","unstructured":"Brugal MT, Domingo-Salvany A, Puig R, Barrio G, de Garcia OP, de la Fuente L: Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005, 100: 981-989. 10.1111\/j.1360-0443.2005.01089.x.","journal-title":"Addiction"},{"key":"339_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1360-0443.1996.tb02290.x","volume":"91","author":"S Darke","year":"1996","unstructured":"Darke S, Ross J, Hall W: Overdose among heroin users in Sydney, Australia: II. Responses to overdose. Addiction. 1996, 91: 413-417. 10.1111\/j.1360-0443.1996.tb02290.x.","journal-title":"Addiction"},{"key":"339_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1360-0443.2002.00058.x","volume":"97","author":"MT Brugal","year":"2002","unstructured":"Brugal MT, Barrio G, De LF, Regidor E, Royuela L, Suelves JM: Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction. 2002, 97: 319-327. 10.1046\/j.1360-0443.2002.00058.x.","journal-title":"Addiction"},{"key":"339_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/bmj.313.7054.402","volume":"313","author":"M Gossop","year":"1996","unstructured":"Gossop M, Griffiths P, Powis B, Williamson S, Strang J: Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996, 313: 402-10.1136\/bmj.313.7054.402.","journal-title":"BMJ"},{"key":"339_CR12","first-page":"455","volume":"105","author":"J Cami","year":"1995","unstructured":"Cami J, Domingo-Salvany A: Factores de riesgo en la muerte por hero\u00edna. The risk factors in death from heroin. Med Clin (Barc). 1995, 105: 455-456.","journal-title":"Med Clin (Barc)"},{"key":"339_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1477-7517-6-18","volume":"6","author":"PG Miller","year":"2009","unstructured":"Miller PG: Safe using messages may not be enough to promote behaviour change amongst injecting drug users who are ambivalent or indifferent towards death. Harm Reduct J. 2009, 6: 18-10.1186\/1477-7517-6-18.","journal-title":"Harm Reduct J"},{"key":"339_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/bmj.326.7386.442","volume":"326","author":"KA Sporer","year":"2003","unstructured":"Sporer KA: Strategies for preventing heroin overdose. BMJ. 2003, 326: 442-444. 10.1136\/bmj.326.7386.442.","journal-title":"BMJ"},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.7326\/0003-4819-130-7-199904060-00019","volume":"130","author":"KA Sporer","year":"1999","unstructured":"Sporer KA: Acute heroin overdose. Ann Intern Med. 1999, 130: 584-590. 10.7326\/0003-4819-130-7-199904060-00019.","journal-title":"Ann Intern Med"},{"key":"339_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","volume":"159","author":"IA Binswanger","year":"2013","unstructured":"Binswanger IA, Blatchford PJ, Mueller SR, Stern MF: Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013, 159: 592-600. 10.7326\/0003-4819-159-9-201311050-00005.","journal-title":"Ann Intern Med"},{"key":"339_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2471\/BLT.12.111054","volume":"91","author":"M Torrens","year":"2013","unstructured":"Torrens M, Fonseca F, Castillo C, Domingo-Salvany A: Methadone maintenance treatment in Spain: the success of a harm reduction approach. Bull World Health Organ. 2013, 91: 136-414. 10.2471\/BLT.12.111054.","journal-title":"Bull World Health Organ"},{"key":"339_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/jurban\/jtg032","volume":"80","author":"KH Seal","year":"2003","unstructured":"Seal KH, Downing M, Kral AH, Singleton-Banks S, Hammond JP, Lorvick J, Ciccarone D, Edlin BR: Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay area. J Urban Health. 2003, 80: 291-301. 10.1093\/jurban\/jtg032.","journal-title":"J Urban Health"},{"key":"339_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.drugpo.2010.06.003","volume":"22","author":"M Neira-Leon","year":"2011","unstructured":"Neira-Leon M, Barrio G, Bravo MJ, Brugal MT, de la Fuente L, Domingo-Salvany A, Pulido J, Santos S, Project Itinere Group: Infrequent opioid overdose risk reduction behaviours among young adult heroin users in cities with wide coverage of HIV prevention programmes. Int J Drug Policy. 2011, 22: 16-25. 10.1016\/j.drugpo.2010.06.003.","journal-title":"Int J Drug Policy"},{"key":"339_CR20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/003335490712200313","volume":"122","author":"DI Heller","year":"2007","unstructured":"Heller DI, Stancliff S: Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City. Public Health Rep. 2007, 122: 393-397.","journal-title":"Public Health Rep"},{"key":"339_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1300\/J069v25n03_11","volume":"25","author":"S Maxwell","year":"2006","unstructured":"Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S: Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006, 25: 89-96.","journal-title":"J Addict Dis"},{"key":"339_CR22","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/bmj.322.7291.895","volume":"322","author":"K Dettmer","year":"2001","unstructured":"Dettmer K, Saunders B, Strang J: Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ. 2001, 322: 895-896. 10.1136\/bmj.322.7291.895.","journal-title":"BMJ"},{"key":"339_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.drugpo.2009.01.003","volume":"21","author":"KD Wagner","year":"2010","unstructured":"Wagner KD, Valente TW, Casanova M, Partovi SM, Mendenhall BM, Hundley JH, Gonzalez M, Unger JB: Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010, 21: 186-193. 10.1016\/j.drugpo.2009.01.003.","journal-title":"Int J Drug Policy"},{"key":"339_CR24","volume-title":"Informe 2011. Situaci\u00f3n y tendencias de los problemas de drogas en Espa\u00f1a. Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas","author":"Observatorio Espa\u00f1ol de la Droga y las Toxicoman\u00edas","year":"2011","unstructured":"Observatorio Espa\u00f1ol de la Droga y las Toxicoman\u00edas: Informe 2011. Situaci\u00f3n y tendencias de los problemas de drogas en Espa\u00f1a. Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Drogas. 2011, Madrid: Ministerio de Sanidad y Pol\u00edtica Social"},{"key":"339_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/eurpub\/cki168","volume":"16","author":"AM Bargagli","year":"2006","unstructured":"Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, Brugal T, Vicente J, COSMO European Group: Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health. 2006, 16: 198-202.","journal-title":"Eur J Public Health"},{"key":"339_CR26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.20882\/adicciones.613","volume":"11","author":"M Contel","year":"1999","unstructured":"Contel M, Gual A, Colom J: Test para la identificacion de trastornos por uso de alcohol (AUDIT): traduccion y validacion del AUDIT al catalan y castellano. Addicciones. 1999, 11: 337-347.","journal-title":"Addicciones"},{"key":"339_CR27","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1590\/S0034-89102008000600003","volume":"42","author":"LM Coutinho","year":"2008","unstructured":"Coutinho LM, Scazufca M, Menezes PR: Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica. 2008, 42: 992-998. 10.1590\/S0034-89102008000600003.","journal-title":"Rev Saude Publica"},{"key":"339_CR28","first-page":"117","volume":"12","author":"SA Maisto","year":"1990","unstructured":"Maisto SA, McKay JR, Connors GJ: Self-report issues in substance abuse: state of the art and future directions. Behav Assess. 1990, 12: 117-134.","journal-title":"Behav Assess"},{"key":"339_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1360-0443.2011.03759.x","volume":"107","author":"G Barrio","year":"2012","unstructured":"Barrio G, Bravo MJ, Brugal MT, Diez M, Regidor E, Belza MJ, de la Fuente L, Itinere Working Group: Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates. Addiction. 2012, 107: 1111-1122. 10.1111\/j.1360-0443.2011.03759.x.","journal-title":"Addiction"},{"key":"339_CR30","volume-title":"Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users","author":"World Health Organization, United Nations Office on Drugs and Crime, United Nations AIDS","year":"2009","unstructured":"World Health Organization, United Nations Office on Drugs and Crime, United Nations AIDS: Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. 2009, Geneva"},{"key":"339_CR31","volume-title":"Effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug users","author":"World Health Organization","year":"2004","unstructured":"World Health Organization: Effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug users. 2004, Geneva"},{"key":"339_CR32","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","volume":"102","author":"M Davoli","year":"2007","unstructured":"Davoli M, Bargagli AM, Perucci CA, Schifano P, Belleudi V, Hickman M, Salamina G, Diecidue R, Vigna-Taglianti F, Faggiano F, VEdeTTE Study Group: Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007, 102: 1954-1959. 10.1111\/j.1360-0443.2007.02025.x.","journal-title":"Addiction"},{"key":"339_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.drugalcdep.2013.03.014","volume":"132","author":"A Hakansson","year":"2013","unstructured":"Hakansson A, Berglund M: All-cause mortality in criminal justice clients with substance use problems\u2014a prospective follow-up study. Drug Alcohol Depend. 2013, 132: 499-504. 10.1016\/j.drugalcdep.2013.03.014.","journal-title":"Drug Alcohol Depend"},{"key":"339_CR34","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1360-0443.2008.02182.x","volume":"103","author":"TC Green","year":"2008","unstructured":"Green TC, Heimer R, Grau LE: Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction. 2008, 103: 979-989. 10.1111\/j.1360-0443.2008.02182.x.","journal-title":"Addiction"},{"key":"339_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7517-4-3","volume":"4","author":"TM Piper","year":"2007","unstructured":"Piper TM, Rudenstine S, Stancliff S, Sherman S, Nandi V, Clear A, Galea S: Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J. 2007, 4: 3-10.1186\/1477-7517-4-3.","journal-title":"Harm Reduct J"},{"key":"339_CR36","volume-title":"Preventing Opioid Overdoses in Europe: A Critical Assessment of Known Risk Factors and Preventative Measures","author":"M Frisher","year":"2012","unstructured":"Frisher M, Baldacchino A, Crome I, Bloor R: Preventing Opioid Overdoses in Europe: A Critical Assessment of Known Risk Factors and Preventative Measures. 2012, EMCDDA, Lisbon: European Monitoring Centre for Drugs and Drug Addiction Technical paper"},{"key":"339_CR37","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1007\/s11524-011-9600-7","volume":"88","author":"AS Bennett","year":"2011","unstructured":"Bennett AS, Bell A, Tomedi L, Hulsey EG, Kral AH: Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. J Urban Health. 2011, 88: 1020-1030. 10.1007\/s11524-011-9600-7.","journal-title":"J Urban Health"},{"key":"339_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11524-010-9495-8","volume":"87","author":"L Enteen","year":"2010","unstructured":"Enteen L, Bauer J, McLean R, Wheeler E, Huriaux E, Kral AH, Bamberger JD: Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health. 2010, 87: 931-941. 10.1007\/s11524-010-9495-8.","journal-title":"J Urban Health"},{"key":"339_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1472-6963-11-174","volume":"11","author":"KI Marchand","year":"2011","unstructured":"Marchand KI, Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Schechter MT: Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency. BMC Health Serv Res. 2011, 11: 174-10.1186\/1472-6963-11-174.","journal-title":"BMC Health Serv Res"},{"key":"339_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10198-009-0204-z","volume":"11","author":"JI Anton","year":"2010","unstructured":"Anton JI, de Munoz BR: Health care utilisation and immigration in Spain. Eur J Health Econ. 2010, 11: 487-498. 10.1007\/s10198-009-0204-z.","journal-title":"Eur J Health Econ"},{"key":"339_CR41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.20882\/adicciones.136","volume":"26","author":"N Saigi","year":"2014","unstructured":"Saigi N, Espelt A, Folch C, Sarasa-Renedo A, Castellano Y, Majo X, Mero\u00f1o M, Brugal MT, Casabona J, REDAN Group: Differences in illegal drug consumption between native and immigrants in a large sample of injected drug users in Catalonia (Spain). Adicciones. 2014, 26: 69-76.","journal-title":"Adicciones"},{"key":"339_CR42","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/j.1360-0443.2011.03443.x","volume":"106","author":"YF Huang","year":"2011","unstructured":"Huang YF, Kuo HS, Lew-Ting CY, Tian F, Yang CH, Tsai TI, Gange SJ, Nelson KE: Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan. Addiction. 2011, 106: 1437-1445. 10.1111\/j.1360-0443.2011.03443.x.","journal-title":"Addiction"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7517-11-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:40:07Z","timestamp":1630564807000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/1477-7517-11-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,22]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1186\/1477-7517-11-33","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,22]]},"assertion":[{"value":"31 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}